Ligand Pharmaceuticals
LGND
LGND
210 hedge funds and large institutions have $1.17B invested in Ligand Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 72 increasing their positions, 71 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+15
Holders Change %
+7.69%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
72
Reduced
71
Closed
17
Calls
$4.48M
Puts
$2.88M
Net Calls
+$1.59M
Net Calls Change
-$1.4M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$14.5M |
| 2 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$13.7M |
| 3 |
Man Group
London,
United Kingdom
|
+$10.3M |
| 4 |
BlackRock
New York
|
+$8.66M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.65M |
Top Sellers
| 1 |
CC
Chicago Capital
Chicago,
Illinois
|
-$9.2M |
| 2 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
-$5.19M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$3.74M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$2.47M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.2M |
